Precise and Accurate CHN Data from Low Weight Samples
A new report from Exeter Analytical demonstrates how the Model 440 CHN Analyser provides precise and accurate determination of percentage carbon, hydrogen and nitrogen on samples as small as 0.3 mg.
Using Atropine (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl) 3-hydroxy-2-phenylpropanoate) as the test compound the Model 440 produced data from 0.3 mg samples which only varied within +/- 0.12% of the theoretical CHN values. In environments such as pharmaceutical research and synthetic chemistry laboratories, where the weight of new compounds for analytical purposes is often limited, the ability to reliably generate reliable CHN data on sub 0.5 milligram samples is highly valuable.
The Exeter Analytical Model 440 is a static combustion CHN Elemental Analyser, with a unique horizontal furnace design, which enables easy removal of sample residue between each analysis. Because the Model 440 is able to effectively eliminate troublesome residue build-up, its gas flow characteristics are superior to other CHN Analysers leading to longer-term calibration stability, as well as enhanced accuracy and precision for measured sample data.
Because the Model 440 provides complete control over combustion parameters it is able to reproducibly achieve 100% combustion with the widest range of sample types. Through incorporation of extensive automation in the Model 440 and intuitive software – the percentage Carbon (C), Hydrogen (H) and Nitrogen (N) in samples can be determined in as little as 5 minutes.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance